ID   TGM3L_HUMAN             Reviewed;         706 AA.
AC   O95932; Q5JXU4; Q5JXU5; Q719M2; Q719M3; Q9Y4U8;
DT   10-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   16-AUG-2005, sequence version 3.
DT   15-MAR-2017, entry version 146.
DE   RecName: Full=Protein-glutamine gamma-glutamyltransferase 6;
DE            EC=2.3.2.13;
DE   AltName: Full=Transglutaminase Y;
DE            Short=TGY;
DE            Short=TGase Y;
DE   AltName: Full=Transglutaminase-3-like;
DE            Short=TGase-3-like;
DE   AltName: Full=Transglutaminase-6;
DE            Short=TG6;
DE            Short=TGase-6;
GN   Name=TGM6; Synonyms=TGM3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT VAL-58.
RC   TISSUE=Lung;
RA   Thomas H., Aeschlimann D.;
RT   "A novel transglutaminase expressed in the nervous system.";
RL   Submitted (AUG-2002) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [3]
RP   VARIANTS SCA35 GLY-327 AND TRP-517.
RX   PubMed=21106500; DOI=10.1093/brain/awq323;
RA   Wang J.L., Yang X., Xia K., Hu Z.M., Weng L., Jin X., Jiang H.,
RA   Zhang P., Shen L., Guo J.F., Li N., Li Y.R., Lei L.F., Zhou J., Du J.,
RA   Zhou Y.F., Pan Q., Wang J., Wang J., Li R.Q., Tang B.S.;
RT   "TGM6 identified as a novel causative gene of spinocerebellar ataxias
RT   using exome sequencing.";
RL   Brain 133:3510-3518(2010).
RN   [4]
RP   SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANTS SCA35 GLY-327
RP   AND TRP-517.
RX   PubMed=23206699; DOI=10.1016/j.bbrc.2012.11.069;
RA   Guan W.J., Wang J.L., Liu Y.T., Ma Y.T., Zhou Y., Jiang H., Shen L.,
RA   Guo J.F., Xia K., Li J.D., Tang B.S.;
RT   "Spinocerebellar ataxia type 35 (SCA35)-associated transglutaminase 6
RT   mutants sensitize cells to apoptosis.";
RL   Biochem. Biophys. Res. Commun. 430:780-786(2013).
RN   [5]
RP   VARIANT SCA35 HIS-510.
RX   PubMed=22554020; DOI=10.1111/j.1399-0004.2012.01895.x;
RA   Li M., Pang S.Y., Song Y., Kung M.H., Ho S.L., Sham P.C.;
RT   "Whole exome sequencing identifies a novel mutation in the
RT   transglutaminase 6 gene for spinocerebellar ataxia in a Chinese
RT   family.";
RL   Clin. Genet. 83:269-273(2013).
RN   [6]
RP   VARIANTS SCA35 CYS-111; HIS-510 AND GLU-574 DEL, CHARACTERIZATION OF
RP   VARIANTS SCA35 CYS-111; HIS-510 AND GLU-574 DEL, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=25253745; DOI=10.1212/WNL.0000000000000909;
RA   Guo Y.C., Lin J.J., Liao Y.C., Tsai P.C., Lee Y.C., Soong B.W.;
RT   "Spinocerebellar ataxia 35: Novel mutations in TGM6 with clinical and
RT   genetic characterization.";
RL   Neurology 83:1554-1561(2014).
CC   -!- FUNCTION: Catalyzes the cross-linking of proteins and the
CC       conjugation of polyamines to proteins. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: Protein glutamine + alkylamine = protein N(5)-
CC       alkylglutamine + NH(3). {ECO:0000255|PROSITE-ProRule:PRU10024}.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108; Evidence={ECO:0000250};
CC       Note=Binds up to 3 Ca(2+) cations per subunit. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23206699,
CC       ECO:0000269|PubMed:25253745}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long;
CC         IsoId=O95932-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short;
CC         IsoId=O95932-2; Sequence=VSP_015103, VSP_015104;
CC   -!- DISEASE: Spinocerebellar ataxia 35 (SCA35) [MIM:613908]: A form of
CC       spinocerebellar ataxia, a clinically and genetically heterogeneous
CC       group of cerebellar disorders. Patients show progressive
CC       incoordination of gait and often poor coordination of hands,
CC       speech and eye movements, due to degeneration of the cerebellum
CC       with variable involvement of the brainstem and spinal cord. SCA35
CC       patients commonly show upper limb involvement and torticollis.
CC       There is no cognitive impairment. {ECO:0000269|PubMed:21106500,
CC       ECO:0000269|PubMed:22554020, ECO:0000269|PubMed:23206699,
CC       ECO:0000269|PubMed:25253745}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the transglutaminase superfamily.
CC       Transglutaminase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF540969; AAQ10751.1; -; mRNA.
DR   EMBL; AF540970; AAQ10752.1; -; mRNA.
DR   EMBL; AL049650; CAI22576.1; -; Genomic_DNA.
DR   EMBL; AL031678; CAI22576.1; JOINED; Genomic_DNA.
DR   EMBL; AL049650; CAI22577.1; -; Genomic_DNA.
DR   EMBL; AL031678; CAI22577.1; JOINED; Genomic_DNA.
DR   EMBL; AL031678; CAI22900.1; -; Genomic_DNA.
DR   EMBL; AL049650; CAI22900.1; JOINED; Genomic_DNA.
DR   EMBL; AL031678; CAI22901.1; -; Genomic_DNA.
DR   EMBL; AL049650; CAI22901.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS13025.1; -. [O95932-1]
DR   CCDS; CCDS58761.1; -. [O95932-2]
DR   RefSeq; NP_001241663.1; NM_001254734.1. [O95932-2]
DR   RefSeq; NP_945345.2; NM_198994.2. [O95932-1]
DR   UniGene; Hs.452039; -.
DR   ProteinModelPortal; O95932; -.
DR   SMR; O95932; -.
DR   STRING; 9606.ENSP00000202625; -.
DR   BindingDB; O95932; -.
DR   ChEMBL; CHEMBL2079852; -.
DR   DrugBank; DB00130; L-Glutamine.
DR   iPTMnet; O95932; -.
DR   PhosphoSitePlus; O95932; -.
DR   BioMuta; TGM6; -.
DR   PaxDb; O95932; -.
DR   PeptideAtlas; O95932; -.
DR   PRIDE; O95932; -.
DR   TopDownProteomics; O95932-1; -. [O95932-1]
DR   DNASU; 343641; -.
DR   Ensembl; ENST00000202625; ENSP00000202625; ENSG00000166948. [O95932-1]
DR   Ensembl; ENST00000381423; ENSP00000370831; ENSG00000166948. [O95932-2]
DR   GeneID; 343641; -.
DR   KEGG; hsa:343641; -.
DR   UCSC; uc002wfy.1; human. [O95932-1]
DR   CTD; 343641; -.
DR   DisGeNET; 343641; -.
DR   GeneCards; TGM6; -.
DR   H-InvDB; HIX0040537; -.
DR   HGNC; HGNC:16255; TGM6.
DR   HPA; HPA059196; -.
DR   MalaCards; TGM6; -.
DR   MIM; 613900; gene.
DR   MIM; 613908; phenotype.
DR   neXtProt; NX_O95932; -.
DR   OpenTargets; ENSG00000166948; -.
DR   Orphanet; 319465; Inherited acute myeloid leukemia.
DR   Orphanet; 276193; Spinocerebellar ataxia type 35.
DR   PharmGKB; PA38098; -.
DR   eggNOG; ENOG410IFMV; Eukaryota.
DR   eggNOG; ENOG410XQEZ; LUCA.
DR   GeneTree; ENSGT00760000119108; -.
DR   HOGENOM; HOG000231695; -.
DR   HOVERGEN; HBG004342; -.
DR   InParanoid; O95932; -.
DR   KO; K05624; -.
DR   OMA; HTKAVFQ; -.
DR   OrthoDB; EOG091G030K; -.
DR   PhylomeDB; O95932; -.
DR   TreeFam; TF324278; -.
DR   GenomeRNAi; 343641; -.
DR   PRO; PR:O95932; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000166948; -.
DR   CleanEx; HS_TGM6; -.
DR   Genevisible; O95932; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003810; F:protein-glutamine gamma-glutamyltransferase activity; IDA:MGI.
DR   GO; GO:0018149; P:peptide cross-linking; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 3.
DR   Gene3D; 3.90.260.10; -; 1.
DR   InterPro; IPR023608; Gln_gamma-glutamylTfrase_euk.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002931; Transglutaminase-like.
DR   InterPro; IPR013808; Transglutaminase_AS.
DR   InterPro; IPR008958; Transglutaminase_C.
DR   InterPro; IPR001102; Transglutaminase_N.
DR   PANTHER; PTHR11590; PTHR11590; 1.
DR   Pfam; PF00927; Transglut_C; 2.
DR   Pfam; PF01841; Transglut_core; 1.
DR   Pfam; PF00868; Transglut_N; 1.
DR   PIRSF; PIRSF000459; TGM_EBP42; 1.
DR   SMART; SM00460; TGc; 1.
DR   SUPFAM; SSF49309; SSF49309; 2.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS00547; TRANSGLUTAMINASES; 1.
PE   1: Evidence at protein level;
KW   Acyltransferase; Alternative splicing; Calcium; Complete proteome;
KW   Cytoplasm; Disease mutation; Metal-binding; Neurodegeneration;
KW   Polymorphism; Reference proteome; Spinocerebellar ataxia; Transferase.
FT   CHAIN         1    706       Protein-glutamine gamma-
FT                                glutamyltransferase 6.
FT                                /FTId=PRO_0000213715.
FT   ACT_SITE    274    274       {ECO:0000255|PROSITE-ProRule:PRU10024}.
FT   ACT_SITE    333    333       {ECO:0000255|PROSITE-ProRule:PRU10024}.
FT   ACT_SITE    356    356       {ECO:0000255|PROSITE-ProRule:PRU10024}.
FT   METAL       223    223       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000255}.
FT   METAL       226    226       Calcium 1. {ECO:0000255}.
FT   METAL       228    228       Calcium 1; via carbonyl oxygen.
FT                                {ECO:0000255}.
FT   METAL       303    303       Calcium 2. {ECO:0000250}.
FT   METAL       305    305       Calcium 2. {ECO:0000250}.
FT   METAL       307    307       Calcium 2. {ECO:0000250}.
FT   METAL       309    309       Calcium 2; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       327    327       Calcium 2. {ECO:0000250}.
FT   METAL       396    396       Calcium 3. {ECO:0000250}.
FT   METAL       417    417       Calcium 3; via carbonyl oxygen.
FT                                {ECO:0000250}.
FT   METAL       445    445       Calcium 3. {ECO:0000250}.
FT   METAL       450    450       Calcium 3. {ECO:0000250}.
FT   VAR_SEQ     612    625       VLGPAMVGVAVTVE -> RAYPGASGEGLSPV (in
FT                                isoform 2). {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_015103.
FT   VAR_SEQ     626    706       Missing (in isoform 2).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_015104.
FT   VARIANT      58     58       M -> V (in dbSNP:rs2076405).
FT                                {ECO:0000269|Ref.1}.
FT                                /FTId=VAR_013250.
FT   VARIANT     111    111       R -> C (in SCA35; impairs
FT                                transglutaminase activity;
FT                                dbSNP:rs372250159).
FT                                {ECO:0000269|PubMed:25253745}.
FT                                /FTId=VAR_072179.
FT   VARIANT     327    327       D -> G (in SCA35; decreased
FT                                transglutaminase activity; decreased
FT                                protein stability; dbSNP:rs387907098).
FT                                {ECO:0000269|PubMed:21106500,
FT                                ECO:0000269|PubMed:23206699}.
FT                                /FTId=VAR_065360.
FT   VARIANT     510    510       D -> H (in SCA35; impairs
FT                                transglutaminase activity;
FT                                dbSNP:rs201964784).
FT                                {ECO:0000269|PubMed:22554020,
FT                                ECO:0000269|PubMed:25253745}.
FT                                /FTId=VAR_072180.
FT   VARIANT     517    517       L -> W (in SCA35; decreased
FT                                transglutaminase activity; decreased
FT                                protein stability; dbSNP:rs387907097).
FT                                {ECO:0000269|PubMed:21106500,
FT                                ECO:0000269|PubMed:23206699}.
FT                                /FTId=VAR_065361.
FT   VARIANT     574    574       Missing (in SCA35; impairs
FT                                transglutaminase activity).
FT                                {ECO:0000269|PubMed:25253745}.
FT                                /FTId=VAR_072181.
SQ   SEQUENCE   706 AA;  79312 MW;  97BBE2043C5FF834 CRC64;
     MAGIRVTKVD WQRSRNGAAH HTQEYPCPEL VVRRGQSFSL TLELSRALDC EEILIFTMET
     GPRASEALHT KAVFQTSELE RGEGWTAARE AQMEKTLTVS LASPPSAVIG RYLLSIRLSS
     HRKHSNRRLG EFVLLFNPWC AEDDVFLASE EERQEYVLSD SGIIFRGVEK HIRAQGWNYG
     QFEEDILNIC LSILDRSPGH QNNPATDVSC RHNPIYVTRV ISAMVNSNND RGVVQGQWQG
     KYGGGTSPLH WRGSVAILQK WLKGRYKPVK YGQCWVFAGV LCTVLRCLGI ATRVVSNFNS
     AHDTDQNLSV DKYVDSFGRT LEDLTEDSMW NFHVWNESWF ARQDLGPSYN GWQVLDATPQ
     EESEGVFRCG PASVTAIREG DVHLAHDGPF VFAEVNADYI TWLWHEDESR ERVYSNTKKI
     GRCISTKAVG SDSRVDITDL YKYPEGSRKE RQVYSKAVNR LFGVEASGRR IWIRRAGGRC
     LWRDDLLEPA TKPSIAGKFK VLEPPMLGHD LRLALCLANL TSRAQRVRVN LSGATILYTR
     KPVAEILHES HAVRLGPQEE KRIPITISYS KYKEDLTEDK KILLAAMCLV TKGEKLLVEK
     DITLEDFITI KVLGPAMVGV AVTVEVTVVN PLIERVKDCA LMVEGSGLLQ EQLSIDVPTL
     EPQERASVQF DITPSKSGPR QLQVDLVSPH FPDIKGFVIV HVATAK
//
